STOCK TITAN

VIVOS INC (RDGL) president purchases 50,000 shares, lifting stake to 1.52M

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

VIVOS INC President Brad Allan Weeks purchased 50,000 shares of Common Stock on 2026-08-10 at $0.0548 per share in an open market or private transaction. Following this purchase, he directly holds 1,521,654 shares of VIVOS INC Common Stock.

Positive

  • None.

Negative

  • None.
Insider Weeks Brad Allan
Role President
Bought 50,000 shs ($3K)
Type Security Shares Price Value
Purchase Common Stock 50,000 $0.0548 $3K
Holdings After Transaction: Common Stock — 1,521,654 shares (Direct)
Shares purchased 50,000 shares Common Stock acquired on 2026-08-10 by President Brad Allan Weeks
Purchase price $0.0548 per share Price paid for VIVOS INC Common Stock on 2026-08-10
Shares owned after transaction 1,521,654 shares Direct holdings of Brad Allan Weeks following the reported purchase
Purchase in open market or private transaction financial
"transaction_code_description: Purchase in open market or private transaction"
Rule 10b5-1 regulatory
"aff_10b5_one is the filing's document-level Rule 10b5-1 checkbox"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
beneficial ownership financial
"Footnotes may indicate any disclaimers of beneficial ownership"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did VIVOS INC (RDGL) report for Brad Allan Weeks?

VIVOS INC reported that President Brad Allan Weeks purchased 50,000 shares of Common Stock on 2026-08-10 at $0.0548 per share. The transaction was classified as a purchase in an open market or private transaction.

How many VIVOS INC (RDGL) shares does Brad Allan Weeks own after this transaction?

After the reported purchase, Brad Allan Weeks directly owns 1,521,654 shares of VIVOS INC Common Stock. This figure reflects his holdings immediately following the acquisition of 50,000 additional shares.

Was the VIVOS INC (RDGL) insider trade made under a Rule 10b5-1 plan?

The filing indicates the Rule 10b5-1 checkbox is not marked as affirming a trading plan. The purchase of 50,000 shares on 2026-08-10 is therefore not identified as executed under a pre-arranged Rule 10b5-1 plan.

What was the purchase price in the latest VIVOS INC (RDGL) insider buy?

Brad Allan Weeks purchased 50,000 VIVOS INC Common Stock shares at a price of $0.0548 per share. The transaction is described as a purchase in an open market or private transaction on 2026-08-10.

Is the recent VIVOS INC (RDGL) insider transaction a buy or a sell?

The reported transaction is a buy. Brad Allan Weeks acquired 50,000 shares of VIVOS INC Common Stock, increasing his direct holdings to 1,521,654 shares following the transaction on 2026-08-10.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Weeks Brad Allan

(Last)(First)(Middle)
C/O VIVOS INC.
1030 N CENTER PARKWAY

(Street)
KENNEWICK WASHINGTON 99336

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
VIVOS INC [ RDGL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/10/2026P50,000A$0.05481,521,654D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Brad Allan Weeks08/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)